RaySearch Laboratories AB announced an extension of its relationship with Centre hospitalier universitaire vaudois (CHUV) in Lausanne, Switzerland, which will include orders for RayStation RayCare and RayIntelligence. 

June 28, 2021 — RaySearch Laboratories AB announced an extension of its relationship with Centre hospitalier universitaire vaudois (CHUV) in Lausanne, Switzerland, which will include orders for RayStation RayCare and RayIntelligence. 

CHUV has been a RayStation customer since 2017 and included in the order is additional RayStation functionality for automated treatment planning and segmentation using machine learning techniques and support for CyberKnife planning. CHUV will become one of the first centers to adopt RayStation’s planning functionality for the Accuray CyberKnife treatment delivery system.

The center will also fully replace its existing oncology information system with RayCare to coordinate and optimize its workflows and treatment management.

In addition, CHUV will be the first center to purchase RayIntelligence, the innovative cloud-based oncology analytics system launched in December 2020. The system simplifies data integration and supports analysis of patient and treatment populations, research activities and workflows.

Going forward, CHUV will conduct all major radiation oncology activities including treatment planning, record and verify, workflow management and data analytics exclusively with RaySearch software.

RaySearch and CHUV will also work togheter on various dimensions of treatment optimization,  operational efficiency including optimal machine utilization and the new treatment technique FLASH radiotherapy. CHUV has pioneered the development of this new technique which makes it possible to deliver the required dose to the patient in a few sessions each lasting a few seconds, rather than in conventional treatments requiring multiple sessions of several minutes.

Prof. Jean Bourhis, CHUV says: “The collaboration between RaySearch and CHUV is entering in a very promising phase, setting up at CHUV a single integrated software platform, connecting all our radiation oncology activities and combining a highly efficient digital workflow management, along with innovative artificial intelligence tools for contouring and dosimetry. We expect to markedly improve the global efficiency, along with increasing the quality and safety of our radiation oncology treatments”.

Johan Löf, founder and CEO, RaySearch, said: “We are very pleased to extend our relationship with CHUV, a world-class center with a focus on using advanced technology to benefit patients. By expanding the existing RayStation installation to a complete suite of RaySearch products at CHUV, we will be able to support an optimization of operational efficiency, improve treatment quality and through RayIntelligence capture all data for improved decision making and further personalize treatments”.

The combined order value is 1,8 M EURO excluding service agreement.

For more information: www.raysearchlabs.com


Related Content

News | Radiation Therapy

December 8, 2022 — A newly updated clinical guideline from the American Society for Radiation Oncology (ASTRO) provides ...

Time December 08, 2022
arrow
News | RSNA

December 3, 2022 — Results from its Orviglance Food Effect study were presented by Ascelia Pharma, a biopharmaceutical ...

Time December 03, 2022
arrow
News | Prostate Cancer

December 2, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time December 02, 2022
arrow
News | RSNA | By Christine Book

November 27, 2022 — Among dozens of technical exhibit visits, informative discussions, and captivating Plenary Session ...

Time November 27, 2022
arrow
Videos | ASTRO

Dr. Frank A. Vicini, MD, FACR, FASTRO, FABS, who is a radiation oncologist with GenesisCare, discussed his findings from ...

Time November 09, 2022
arrow
News | Radiation Therapy

November 8, 2022 — Elekta announced that Elekta Esprit, a new Leksell Gamma Knife radiosurgery platform, received FDA ...

Time November 08, 2022
arrow
News | Artificial Intelligence

Nov. 4, 2022 — Guerbet announced an agreement with Merative formalizing the termination of their collaboration initiated ...

Time November 05, 2022
arrow
News | Artificial Intelligence

Nov. 4, 2022 — The U.S. Food and Drug Administration (FDA) is recommending health care providers discuss alternative ...

Time November 05, 2022
arrow
News | Proton Therapy

November 3, 2022 — Mevion Medical Systems, the leading provider of compact proton therapy systems for use in radiation ...

Time November 03, 2022
arrow
Feature | Lung Imaging | By Christine Book

The pace of new lung cancer screening initiatives, published research and collective efforts of organizations and ...

Time November 03, 2022
arrow
Subscribe Now